All tenders
75A50123C00062
DEVELOPING A NEXT-GENERATION VACCINE THAT DRIVES (A) MORE DURABLE AND BROAD ANTI-SPIKE NEUTRALIZING ANTIBODIES (NABS) AGAINST VARIANTS OF CONCERN (VOCS), INCLUDING THOSE NOT INCLUDED IN THE VACCINE, AND (B) T CELLS REACTIVE AGAINST CONSERVED TARGETS
Office of Assistant Secretary for Preparedness and Response · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75A50123C00062
- Issuing organization
- Office of Assistant Secretary for Preparedness and Response · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- DEVELOPING A NEXT-GENERATION VACCINE THAT DRIVES (A) MORE DURABLE AND BROAD ANTI-SPIKE NEUTRALIZING ANTIBODIES (NABS) AGAINST VARIANTS OF CONCERN (VOCS), INCLUDING THOSE NOT INCLUDED IN THE VACCINE, AND (B) T CELLS REACTIVE AGAINST CONSERVED TARGETS
- Source
- USASpending (Federal)
- Source ID
- usa-75A50123C00062
Details
- Location
- United States
Description
DEVELOPING A NEXT-GENERATION VACCINE THAT DRIVES (A) MORE DURABLE AND BROAD ANTI-SPIKE NEUTRALIZING ANTIBODIES (NABS) AGAINST VARIANTS OF CONCERN (VOCS), INCLUDING THOSE NOT INCLUDED IN THE VACCINE, AND (B) T CELLS REACTIVE AGAINST CONSERVED TARGETS Awarded to: GRITSTONE BIO, INC. Agency: Department of Health and Human Services Sub-agency: Office of Assistant Secretary for Preparedness and Response Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2023/09/25 12:00:00 AM UTC
- Closing date
- 2025/03/31 12:00:00 AM UTC
Estimated value
$9.9M USD
Classification
Normalized category
Healthcare & Medical